Rheumatic immune-related adverse events associated with cancer immunotherapy: A nationwide multi-center cohort
{{output}}
Objective: Although immune checkpoint inhibitors (ICI) have revolutionized cancer therapy, their use is associated with immune toxicities referred to as immune-related adverse events (irAE). Here we describe the clinical presenta... ...
